6CM
683 Capital Management Portfolio holdings
AUM
$986M
1-Year Return
26.79%
This Quarter Return
+14.38%
1 Year Return
+26.79%
3 Year Return
+135.86%
5 Year Return
+188.43%
10 Year Return
+750.26%
AUM
$999M
AUM Growth
+$12.2M
(+1.2%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-11.92%
Top 10 Holdings %
Top 10 Hldgs %
36.51%
Holding
273
New
130
Increased
21
Reduced
37
Closed
21
Top Buys
| 1 |
BorgWarner
BWA
|
$20.7M |
| 2 |
Hilton Grand Vacations
HGV
|
$20.4M |
| 3 |
Carvana
CVNA
|
$17.7M |
| 4 |
NCR Atleos
NATL
|
$9.96M |
| 5 |
Sarepta Therapeutics
SRPT
|
$6.42M |
Top Sells
| 1 |
Enova International
ENVA
|
$34.3M |
| 2 |
FLG
Flagstar Financial, Inc.
FLG
|
$25.1M |
| 3 |
Vistra
VST
|
$20.2M |
| 4 |
Noble Corp
NE
|
$16.6M |
| 5 |
Phinia Inc
PHIN
|
$9.84M |
Sector Composition
| 1 | Healthcare | 28.47% |
| 2 | Consumer Discretionary | 22.93% |
| 3 | Financials | 12.63% |
| 4 | Materials | 5.87% |
| 5 | Industrials | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Iovance Biotherapeutics
IOVA
$792M
| $14.2M | 1.17% |
1,750,000
-300,000
| -15% | -$2.44M |
|
27
Invivyd
IVVD
$201M
| $14.2M | 1.16% |
3,600,000
-400,000
| -10% | -$1.58M |
|
28
Cardlytics
CDLX
$48.8M
| $14.1M | 1.16% |
1,535,000
-225,070
| -13% | -$2.07M |
|
29
Garrett Motion
GTX
$2.62B
| $14.1M | 1.16% |
1,461,532
+61,532
| +4% | +$595K |
|
30
RXO
RXO
$2.67B
| $13.7M | 1.12% |
590,000
-60,000
| -9% | -$1.4M |
|
|
31
Noble Corp
NE
$4.56B
| $12M | 0.99% |
250,000
-344,900
| -58% | -$16.6M |
|
32
Valaris
VAL
$3.56B
| $12M | 0.98% |
175,000
-40,000
| -19% | -$2.74M |
|
33
Phathom Pharmaceuticals
PHAT
$824M
| $11.7M | 0.96% |
1,280,000
+180,000
| +16% | +$1.64M |
|
34
Immatics
IMTX
$660M
| $11.6M | 0.95% |
1,100,000
+20,000
| +2% | +$211K |
|
35
Viking Therapeutics
VKTX
$2.96B
| $11.5M | 0.95% |
620,000
-5,000
| -0.8% | -$93.1K |
|
36
uniQure
QURE
$946M
| $11.5M | 0.94% |
1,693,000
+118,000
| +7% | +$799K |
|
37
Harmony Biosciences
HRMY
$2.1B
| $10.5M | 0.86% |
325,000
-25,000
| -7% | -$808K |
|
|
38
NCR Atleos
NATL
$2.91B
| $9.96M | 0.82% |
+410,000
| New | +$9.96M |
|
|
39
Sarepta Therapeutics
SRPT
$1.93B
| $8.35M | 0.68% |
86,600
+66,600
| +333% | +$6.42M |
|
|
CRESY
40
Cresud
CRESY
$584M
| $8.21M | 0.67% |
865,853
-547,944
| -39% | -$5.19M |
|
41
Sea Limited
SE
$112B
| $8.1M | 0.66% |
200,000
| – | – |
|
|
ITOS
42
DELISTED
iTeos Therapeutics
ITOS
| $7.83M | 0.64% |
715,000
-95,000
| -12% | -$1.04M |
|
43
Apellis Pharmaceuticals
APLS
$3.54B
| $7.78M | 0.64% |
130,000
-110,000
| -46% | -$6.58M |
|
44
KNOT Offshore Partners
KNOP
$280M
| $7.2M | 0.59% |
1,249,219
+102,718
| +9% | +$592K |
|
45
Teck Resources
TECK
$16.1B
| $6.34M | 0.52% |
150,000
-65,000
| -30% | -$2.75M |
|
46
Frontier Communications
FYBR
$9.3B
| $6.34M | 0.52% |
250,000
-200,000
| -44% | -$5.07M |
|
|
ARMN
47
Aris Mining
ARMN
$1.8B
| $6.27M | 0.51% |
1,900,000
-415,900
| -18% | -$1.37M |
|
|
48
Phinia Inc
PHIN
$2.27B
| $5.3M | 0.43% |
175,000
-325,000
| -65% | -$9.84M |
|
|
CCTS
49
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
| $4.92M | 0.4% |
450,000
| – | – |
|
|
AFMD
50
DELISTED
Affimed
AFMD
| $4.38M | 0.36% |
700,000
-122,500
| -15% | -$766K |
|